Dr. Lorenc says patients ask him about peptides every week, and he pushes back on the idea that buzz on social feeds means the evidence is there.
Recap by typeshit. Post by @drzpaullorenc on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A law firm ad offers free case evaluations to Zepbound users who developed NAION, an optic nerve condition, and points to clinical studies on the risk.
A case study of a 58-year-old knee patient walks through lean mass loss, sarcopenia risk and tendon changes for people on GLP-1 drugs during rehab.
Loading…